Skip to content

13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC

SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-12 16:14:50 UTC, with 70 holding rows worth $854,443,588.

Accession
0001420506-26-002577
Filed
2026-11-12
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 70 entries on the cover page, a total value of $854,443,588 stated on the cover page (in dollars after the unit check, H1), rows summing to $854,443,588 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerSilverArc Capital, LLC 028-20993

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KODIAK SCIENCES INC50015M109COM750,170$71,116,116dollars as filed
CELCUITY INC15102K100COM803,193$63,869,907dollars as filed
COGENT BIOSCIENCES INC19240Q201COM1,574,698$50,421,830dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK1,148,689$46,671,234dollars as filed
IMMUNOME INC45257U108COM2,092,715$45,014,300dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM3,112,773$37,135,382dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK3,745,990$37,010,381dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*152,175$34,670,030dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM348,317$33,165,003dollars as filed
BIOGEN INC COM09062X103Stock112,790$25,477,005dollars as filed
IMMUNOVANT INC45258J102COM624,055$21,080,578dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM236,582$20,831,045dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock247,918$20,649,090dollars as filed
ERASCA INC COM29479A108Stock1,330,455$19,504,470dollars as filed
ABIVAX SA-00370M103SPONSORED ADS175,699$17,397,715dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW487,589$15,802,759dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK5,950,000$14,815,500dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW151,151$13,456,974dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS345,946$13,166,705dollars as filed
HELIX ACQUISITION CORP IIIG4444S107USD CL A ORD SHS1,208,030$12,829,279dollars as filed
ALKERMES PLCG01767105SHS300,427$12,173,302dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B902COM NEW370,700$12,014,387dollars as filedcall
C4 THERAPEUTICS INC12529R107COM STK3,454,647$11,503,975dollars as filed
AVALYN PHARMA INC05348Y105COMMON STOCK378,352$10,779,248dollars as filed
ORIC PHARMACEUTICALS INC68622P909CALL702,400$9,461,328dollars as filedcall
CERUS CORP157085101COM3,950,595$9,402,416dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK6,565,960$9,126,684dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock334,057$9,009,517dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS717,356$8,923,909dollars as filed
RAINIER ACQUISITION CORPG73591110UNIT853,875$8,709,525dollars as filed
COMPUGEN LTDM25722105ORD3,586,785$8,536,548dollars as filed
SAVARA INC805111101COM1,518,833$7,837,178dollars as filed
VAXCYTE INC COM92243G108Stock125,080$7,117,052dollars as filed
Yarrow Bioscience, Inc.92941V407Common Stock, $0.0001 par value301,919$6,799,216dollars as filed
IBIO INC451033708CMN5,357,088$6,321,364dollars as filed
ARCTURUS THERAPEUTICS HLDGS03969T109COM459,899$6,296,017dollars as filed
MONTE ROSA THERAPEUTICS INC61225M902COM525,000$6,263,250dollars as filedcall
PRAXIS PRECISION MEDICINES I74006W207COM NEW19,753$5,752,666dollars as filed
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL AG52694109Stock75,697$5,647,753dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock121,452$5,567,360dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK760,337$5,497,237dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK594,027$4,906,663dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM247,418$4,651,458dollars as filed
BENITEC BIOPHARMA INC08205P209COMMON STOCK443,109$4,431,090dollars as filed
Research Alliance Corp Iii Ord Shs Cl AG75226103Common Stock404,728$4,383,204dollars as filed
BLOSSOMHILL THERAPEUTICS INC095130100COM202,104$3,767,219dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW124,098$3,690,675dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW693,441$3,640,565dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS301,962$3,501,916dollars as filed
Adlai Nortye00704R109SPONSORED ADS216,617$3,465,872dollars as filed
PALISADE BIO INC696389402COMMON STOCK2,335,602$3,153,063dollars as filed
DISC MEDICINE INC COM254604101Stock47,312$3,097,044dollars as filed
ABSCI CORPORATION00091E959COM254,700$2,743,119dollars as filedput
TELA BIO INC872381108COM2,137,201$2,457,781dollars as filed
ZEVRA THERAPEUTICS INC COM NEW488445206Stock200,260$2,196,852dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM160,552$2,162,635dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock158,964$2,133,297dollars as filed
MODERNA INC60770K107COM10,000$1,925,700dollars as filed
ELUTIA INC05479K106CL A COM2,192,980$1,732,454dollars as filed
FULCRUM THERAPEUTICS INC359616909COM391,900$1,450,030dollars as filedcall
UNIQURE NVN90064101SHS56,704$1,369,969dollars as filed
ACHIEVE LIFE SCIENCES INC004468500COMMON STOCK158,950$1,285,906dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock238,541$1,254,726dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock35,524$1,193,606dollars as filed
ZURA BIO LTDG9TY5A901CALL242,200$1,007,552dollars as filedcall
CAMP4 THERAPEUTICS CORP13463J101COM183,063$739,575dollars as filed
ANNEXON INC03589W902COM131,500$556,245dollars as filedcall
ZURA BIO LTDG9TY5A101COMMON STOCK100,000$416,000dollars as filed
CELLECTAR BIOSCIENCES INC15117F880COM NEW151,118$278,057dollars as filed
Adagio Med Hldgs Inc Com00534B100Common Stock170,460$26,080dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-26-002577this filing2026-11-12